Bearish engulfing, Rsi needs a cool off and could pullback to breakout area and support at 1484
Watch the falling wedge might breakout the next days towards 11000$
Let's see if the bottom is in, needs to breakout of the Wedge
Xbrane Biopharma AB is a biotechnology company which develops and manufactures biosimilars. Xbrane has a patented protein production platform and world-leading expertise within biosimilar development. Xbrane’s headquarter is located in Solna, just outside of Stockholm, and the company has research and development facilities in Sweden and in Italy. Biosimilars...
AIM Has a Gap to fill & seen big unsual buying. Has a very Low float. A Biotech stock targeting diffrent cancers, a lot of data due throughout 2020 - Triple-Negative Breast Cancer ; Phase 1 data due 2Q - Colorectal cancer ; Phase 2 date due 2Q - Ovarian cancer ; Phase 1 interim data due 1Q - Ovarian cancer ; Phase 2 data due 4Q
wait for volume to back it up, has a gap to fill at 42 Recent news with Uber making flying taxi with Hyundai and CEO sold all his Stock
On the watchlist VBI-1501 Phase 2 trial to start 1H 2020 Sci-B-Vac - CONSTANT Phase 3 data due early january BRII-179 (VBI-2601) Phase 2 data due 2H 2020
Catalysts FPA144 + chemo Phase 3 futility analysis due 1H 2020 FPA150 Phase 1b Ovarian cancer data due 1H 2020 Cabiralizumab (FPA008) and Opdivo (nivolumab) Phase 2 Data due 2H 2020 - High hedge fund buying in December - BVF Partners holds a 10% ownership, Frpx Ranks 22 in their portfolio RENAISSANCE TECHNOLOGIES holds a 3.6% stake in the company
SGX301 Phase 3 top line data due 1Q 2020 SGX942 Phase 3 top line data due 2Q 2020 RiVax Phase 1 initiated, safety data due 2Q & 4Q 2020 Let's see if it will continue running or we can get a flag/pullback to the breakout area before entering Bias: long, wait for pullback
AGRX - Agile Therapeutics, Inc. The biotech/heathcare hedge fun PERCEPTIVE ADVISORS LLC has been increasing their stake in the company and currently owns 11,919,925 shares and that ranks AGRX the 34 largest holding. TWIRLA - 30 October Advisory committee meeting voted 14-1 in favor PDUFA is due the 16 FEB AGRX will Present at the 38th Annual J.P. Morgan...
Citius recently Announced Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial Top line data due for 1H 2020 insider Own 42.50% Shs Float 16.64M Market Cap 28.70M Increase in hedge fund holdings
PELOTON - PTON started to look like it would be breaking out and heading for a double top which would be my original setup for a short position. Anyways, it didn't go like that, not enough volume to back up a breakout and to sustain the gains, green to red move. So a new opportunity has arised, short from current level at resistance down to support level at 24....
TSLA has two Gaps to fill, eventually all gaps will be filled or not. Time will tell, I will remain patience and neutral for now until we get a sell signal, earnings the 18 of Februar might be the catalyst for the sell side. Bias: Short, if it breaks down, forming a bearish engulfing or breaks out of the steep trendline to the downside Only looking to buy if it...
Crowdstrike Breaking out of the triangle with big volume, lets see if it will maintain the gains througout the trading day
Advanced Emissions Solutions, Inc Highlights: Alta Fundamental Advisers LLC manages $328,840,000 and owns 202,038 shares of ADES which is their 2 largest holding. Insider Trans 171.28% Shs Float 18.04M Market Cap 198.15M Gross Margin 34.50% EPS past 5Y 33.40% P/E Ratio 6.18 Consensus Price Target: $18.00 ADES provides solutions to customers in coal-fired power...
Weekly MACD is telling the story, buy at dips above signal line. Recently broken out of 4 year resistance. Through its subsidiaries it distributes Services, electronics and hardware for the cable television and wireless/cable telecommunication industries. Subsidiaries: Nave Communications - E-recycling, Logistics & Warehousing, Inventory Stock Programs,...